Article

Immunization with recombinant accessory protein-deficient SARS-CoV-2 protects against lethal challenge and viral transmission

2022-03-14

Abstract excerpt

<h4>ABSTRACT</h4> Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has led to a worldwide Coronavirus Disease 2019 (COVID-19) pandemic. Despite high efficacy of the authorized vaccines, protection against the surging variants of concern (VoC) was less robust. Live-attenuated vaccines (LAV) have been shown to elicit robust and long-term protection by induction of host innate and adaptive immune respons...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 9d20239d-113a-5ff3-801a-d054516890d4
DOI: 10.1101/2022.03.13.484172

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Immunization with recombinant accessory protein-deficient SARS-CoV-2 protects against lethal challenge and viral transmissionDOI 10.1101/2022.03.13.484172Read

Immunization with Recombinant Accessory Protein-Deficient SARS-CoV-2 Protects against Lethal Challenge and Viral TransmissionSemantic proximity Read

A live-attenuated SARS-CoV-2 vaccine candidate with accessory protein deletionsSemantic proximity Read

Intranasal delivery of a rationally attenuated SARS-CoV-2 is immunogenic and protective in Syrian hamstersSemantic proximity Read

Vaccinia virus-based vaccines confer protective immunity against SARS-CoV-2 virus in Syrian hamstersSemantic proximity Read

Single immunization with recombinant ACAM2000 vaccinia viruses expressing the spike and the nucleocapsid proteins protect hamsters against SARS-CoV-2 caused clinical diseaseSemantic proximity Read

SARS-CoV-2 ORF8: A Rapidly Evolving Immune and Viral Modulator in COVID-19Semantic proximity Read

Development of safe and highly protective live-attenuated SARS-CoV-2 vaccine candidates by genome recoding.Semantic proximity Read

Evolving SARS-CoV-2 Vaccines: From Current Solutions to Broad-Spectrum ProtectionSemantic proximity Read

A live attenuated SARS-CoV-2 vaccine constructed by dual inactivation of NSP16 and ORF3aSemantic proximity Read

Development of a Recombinant Single-Cycle Influenza Viral Vector as an Intranasal Vaccine against SARS-CoV-2 and SARS-like BetacoronavirusesSemantic proximity Read

Protection of Hamsters Challenged with SARS-CoV-2 after Two Doses of MVC-COV1901 Vaccine Followed by a Single Intranasal Booster with Nanoemulsion Adjuvanted S-2P VaccineSemantic proximity Read

Broad immunity to SARS-CoV-2 variants of concern mediated by a SARS-CoV-2 receptor-binding domain protein vaccineSemantic proximity Read